Work

A phase II study of intermittent sunitinib in previously untreated patients (pts) with metastatic renal cell carcinoma (mRCC).

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.tps4684

Authors: Laura S. Wood, Robert Dreicer, Jorge A. Garcia, Timothy D. Gilligan, Khaled B. Ali, Housam Haddad, Shetal N. Shah, Paul Elson, Brian I. Rini

Institution: Cleveland Clinic

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4235224753

Cites:

Cited by:

Related to: 10